Publications
77
Citations
1,243
Est. group size
—
Recurring co-author estimate
Active years
42
Publishing since 1984
Satya Kurada studies gastrointestinal diseases, with a focus on inflammatory bowel disease (such as Crohn's disease) and celiac disease, including cases where these conditions overlap. The research spans both clinical work (patient outcomes, treatments, diet, and drug therapies) and laboratory studies of how intestinal inflammation, scarring (fibrosis), and fat accumulation develop at the cellular level.
Publication activity has been fairly steady over the last decade with year-to-year fluctuation, averaging around 3-4 publications per year over the most recent five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- PATIENTS WITH OVERLAP OF INFLAMMATORY BOWEL AND CELIAC DISEASE HAVE A HIGHER PREVALENCE OF AUTOIMMUNE DISORDERS AND AN INCREASED USE OF IMMUNOMODULATORS AND BIOLOGICS COMPARED TO SUBJECTS WITH INFLAMMATORY BOWEL DISEASE ALONE
Gastroenterology · 2025
- PATIENTS WITH OVERLAP OF INFLAMMATORY BOWEL AND CELIAC DISEASE HAVE A HIGHER PREVALENCE OF AUTOIMMUNE DISORDERS AND AN INCREASED USE OF IMMUNOMODULATORS AND BIOLOGICS COMPARED TO SUBJECTS WITH INFLAMMATORY BOWEL DISEASE ALONE
Inflammatory Bowel Diseases · 2025
- S4904 Leukocytoclastic Vasculitis in a Patient With Crohn’s Disease on Anti-TNF-α Therapy
The American Journal of Gastroenterology · 2025
- Creeping Fat–Derived Free Fatty Acids Induce Hyperplasia of Intestinal Muscularis Propria Muscle Cells: A Novel Link Between Fat and Intestinal Stricture Formation in Crohn’s Disease
Gastroenterology · 2024
- Current and future microbiome-based therapies in inflammatory bowel disease
Current Opinion in Gastroenterology · 2024
- S1013 Gastrointestinal Amyloidosis Preferentially Affects the Small Bowel in Subjects That Have Both Dysmotility and Gastrointestinal Bleed: A Systematic Review
The American Journal of Gastroenterology · 2024
- Pancreatic enzyme supplementation versus placebo for improvement of gastrointestinal symptoms in non-responsive celiac disease: A cross-over randomized controlled trial
Frontiers in Medicine · 2023
- WHICH IS IMPORTANT? GLUTEN FREE DIET OR INFLAMMATORY BOWEL DISEASE MEDICATIONS IN SUBJECTS WITH AN OVERLAP WITH CELIAC DISEASE AND INFLAMMATORY BOWEL DISEASE: OBSERVATIONS FROM A CASE SERIES AT A LARGE ACADEMIC CENTER
Inflammatory Bowel Diseases · 2023
- WHICH IS IMPORTANT? GLUTEN FREE DIET OR INFLAMMATORY BOWEL DISEASE MEDICATIONS IN SUBJECTS WITH AN OVERLAP WITH CELIAC DISEASE AND INFLAMMATORY BOWEL DISEASE: OBSERVATIONS FROM A CASE SERIES AT A LARGE ACADEMIC CENTER
Gastroenterology · 2023
- Biologic agents and small molecules – mechanism of action
Seminars in Colon and Rectal Surgery · 2022
- Activated intestinal muscle cells promote preadipocyte migration: a novel mechanism for creeping fat formation in Crohn’s disease
Gut · 2021
- ACTIVATED INTESTINAL MUSCLE CELLS PROMOTE PREADIPOCYTE MIGRATION: A NOVEL MECHANISM OF CREEPING FAT FORMATION IN CROHN’S DISEASE
Gastroenterology · 2021
- Missing Via Defect Capture Enhancement Using a Novel, High-Precision Array Segmentation Inspection Technique
2021
- CADHERIN-11, AN ESSENTIAL REGULATOR OF CELL-CELL ADHESION UPREGULATED IN IBD PATIENTS, PLAYS ESSENTIAL ROLES IN PROMOTING FIBROBLAST ACTIVATION AND DEVELOPMENT OF INTESTINAL INFLAMMATION AND FIBROSIS
Inflammatory Bowel Diseases · 2021
- CADHERIN-11, AN ESSENTIAL REGULATOR OF CELL-CELL ADHESION UPREGULATED IN IBD PATIENTS, PLAYS ESSENTIAL ROLES IN PROMOTING FIBROBLAST ACTIVATION AND DEVELOPMENT OF INTESTINAL INFLAMMATION AND FIBROSIS
Gastroenterology · 2021
- Gastroenterology×30
- Inflammatory Bowel Diseases×5
- The American Journal of Gastroenterology×4
- Digestive and Liver Disease×3
- Translational research×1
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile